Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-23

Clinical Trial Update: The Effect of Orally Administered L- Arginine on Quadriceps Strenght in Healthy Smokers [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of orally administered L-Arginine on quadriceps strength in healthy smokers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • L-Arginine (L-Arginine)

Snippet

Sponsor: Goranka Radmilović | Conditions: Spirometry, Qadriceps Muscle | Phase 4 | Status: UNKNOWN